Aspirin intake and head and neck cancer: A pooled analysis within the INHANCE consortium
Head & Neck · 2024
DOI: 10.1002/hed.27638 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, 2024. Verfasst von Michele Sassano und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Laryngeal Neoplasms, Head and Neck Neoplasms, Oropharyngeal Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: NIH HHS, NIDCR NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Background
Aspirin intake might be inversely associated with head and neck cancer (HNC). Thus, we investigated this relationship within the International Head and Neck Cancer Epidemiology (INHANCE) consortium.
Methods
Four case–control studies within the INHANCE consortium were included (2024 cases, 4196 controls). Study‐specific odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using logistic regression and subsequently pooled with DerSimonian‐Laird random‐effects model. Nonlinearity of the relationship between duration of intake and HNC was modeled with fractional polynomials.
Results
Aspirin was inversely associated with HNC overall (OR = 0.48; 95% CI: 0.26, 0.91). Results for laryngeal cancer were similar (OR = 0.54; 95% CI: 0.30, 0.96). Analysis on duration of intake confirmed findings for HNC overall, showing also inverse associations for oropharyngeal and laryngeal cancer.
Conclusions
This study suggests that aspirin intake may reduce the risk of HNC, driven mainly by decreases in risk for laryngeal and oropharyngeal cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
- Section of Hygiene, Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
- Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
- Department of Woman and Child Health and Public Health - Public Health Area, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
- Dipartimento Scienze dell'Invecchiamento, Neurologiche, Ortopediche e della Testa-Collo, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
- Dipartimento Patologia Testa Collo e Organi di Senso, Facoltà Medicina e Chirurgia, Università Cattolica Sacro Cuore, Roma, Italy.
ORCID-Profile: Michele Sassano
Förderung
- NIH HHS
- NIDCR NIH HHS
- NCI NIH HHS
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Fondazione AIRC per la ricerca sul cancro ETS
- National Institutes of Health
- National Institute of Dental and Craniofacial Research
- National Cancer Institute
Zitieren
APA
Sassano, M., Taborelli, M., Boccia, S., Cadoni, G., La Vecchia, C., Garavello, W., Lazarus, P., Lee, Y. A., Hashibe, M., & Boffetta, P. (2024). Aspirin intake and head and neck cancer: A pooled analysis within the INHANCE consortium. Head & Neck. https://doi.org/10.1002/hed.27638
Vancouver
Sassano M, Taborelli M, Boccia S, Cadoni G, La Vecchia C, Garavello W, et al. Aspirin intake and head and neck cancer: A pooled analysis within the INHANCE consortium. Head & Neck. 2024. doi:10.1002/hed.27638
BibTeX
@article{Sassano2024,
author = {Sassano, Michele and Taborelli, Martina and Boccia, Stefania and Cadoni, Gabriella and La Vecchia, Carlo and Garavello, Werner and Lazarus, Philip and Lee, Yuan-Chin Amy and Hashibe, Mia and Boffetta, Paolo},
title = {Aspirin intake and head and neck cancer: A pooled analysis within the INHANCE consortium},
journal = {Head & Neck},
year = {2024},
doi = {10.1002/hed.27638}
}
EUVIMED